ZBH - Zimmer Biomet Holdings, Inc.
NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Valuation measures4
| Market cap (intra-day) | 30.00B |
| Enterprise value | 35.50B |
| Trailing P/E | 103.63 |
| Forward P/E | 20.28 |
| PEG ratio (5-yr expected) | 3.70 |
| Price/sales (ttm) | 4.33 |
| Price/book (mrq) | 2.50 |
| Enterprise value/revenue | 4.99 |
| Enterprise value/EBITDA | 21.06 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.00 |
| 52-week change 3 | 4.32% |
| S&P500 52-week change 3 | 0.07% |
| 52-week high 3 | 149.25 |
| 52-week low 3 | 100.39 |
| 50-day moving average 3 | 132.88 |
| 200-day moving average 3 | 121.78 |
Share statistics
| Avg vol (3-month) 3 | 1.35M |
| Avg vol (10-day) 3 | 1.9M |
| Shares outstanding 5 | 209.8M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 208.26M |
| % held by insiders 1 | 0.10% |
| % held by institutions 1 | 91.11% |
| Shares short (14 May 2023) 4 | 2.68M |
| Short ratio (14 May 2023) 4 | 1.85 |
| Short % of float (14 May 2023) 4 | 1.65% |
| Short % of shares outstanding (14 May 2023) 4 | 1.29% |
| Shares short (prior month 13 Apr 2023) 4 | 3.45M |
Dividends & splits
| Forward annual dividend rate 4 | 0.96 |
| Forward annual dividend yield 4 | 0.76% |
| Trailing annual dividend rate 3 | 0.96 |
| Trailing annual dividend yield 3 | 0.75% |
| 5-year average dividend yield 4 | 0.75 |
| Payout ratio 4 | 44.86% |
| Dividend date 3 | 30 Jul 2023 |
| Ex-dividend date 4 | 22 Jun 2023 |
| Last split factor 2 | 103:100 |
| Last split date 3 | 28 Feb 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Mar 2023 |
Profitability
| Profit margin | 6.33% |
| Operating margin (ttm) | 19.86% |
Management effectiveness
| Return on assets (ttm) | 4.12% |
| Return on equity (ttm) | 3.73% |
Income statement
| Revenue (ttm) | 7.11B |
| Revenue per share (ttm) | 33.90 |
| Quarterly revenue growth (yoy) | 10.10% |
| Gross profit (ttm) | 4.92B |
| EBITDA | 2.34B |
| Net income avi to common (ttm) | 449.7M |
| Diluted EPS (ttm) | 2.14 |
| Quarterly earnings growth (yoy) | 1,537.30% |
Balance sheet
| Total cash (mrq) | 330.2M |
| Total cash per share (mrq) | 1.58 |
| Total debt (mrq) | 5.98B |
| Total debt/equity (mrq) | 49.19 |
| Current ratio (mrq) | 1.89 |
| Book value per share (mrq) | 58.28 |
Cash flow statement
| Operating cash flow (ttm) | 1.36B |
| Levered free cash flow (ttm) | 1.39B |
© 2023 Yahoo. All rights reserved.